Week 3 Critical Appraisal of Practice Guidelines

AGREE II INSTRUMENT

7

DOMAIN 1. SCOPE AND PURPOSE

1. The overall objective(s) of the guideline is (are) specifically described.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments:

2. The health question(s) covered by the guideline is (are) specifically described.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

DOMAIN 2. STAKEHOLDER INVOLVEMENT

4. The guideline development group includes individuals from all relevant professional groups.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

5. The views and preferences of the target population (patients, public, etc.) have been sought.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

6. The target users of the guideline are clearly defined.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

DOMAIN 3. RIGOUR OF DEVELOPMENT

7. Systematic methods were used to search for evidence.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments:

8. The criteria for selecting the evidence are clearly described.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

9. The strengths and limitations of the body of evidence are clearly described.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

DOMAIN 3. RIGOUR OF DEVELOPMENT continued

10. The methods for formulating the recommendations are clearly described.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

11. The health benefits, side effects, and risks have been considered in formulating the recommendations.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

12. There is an explicit link between the recommendations and the supporting evidence.

DOMAIN 3. RIGOUR OF DEVELOPMENT continued

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

DOMAIN 3. RIGOUR OF DEVELOPMENT continued

13. The guideline has been externally reviewed by experts prior to its publication.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

14. A procedure for updating the guideline is provided.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

DOMAIN 4. CLARITY OF PRESENTATION

15. The recommendations are specific and unambiguous.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

16. The different options for management of the condition or health issue are clearly presented.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

17. Key recommendations are easily identifiable.

DOMAIN 5. APPLICABILITY

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

DOMAIN 5. APPLICABILITY

18. The guideline describes facilitators and barriers to its application.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

19. The guideline provides advice and/or tools on how the recommendations can be put into practice.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

20. The potential resource implications of applying the recommendations have been considered.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

DOMAIN 5. APPLICABILITY continued

21. The guideline presents monitoring and/or auditing criteria.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

DOMAIN 6. EDITORIAL INDEPENDENCE

Comments

DOMAIN 6. EDITORIAL INDEPENDENCE

22. The views of the funding body have not influenced the content of the guideline.

10

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

23. Competing interests of guideline development group members have been recorded and addressed.

1

Strongly Disagree

2 3 4 5 6 7

Strongly Agree

Comments

OVERALL GUIDELINE ASSESSMENT

For each question, please choose the response which best characterizes the guideline assessed:

1. Rate the overall quality of this guideline.

2. I would recommend this guideline for use.

NOTES

11